Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
An analysis of Medicare patient procedural data by Dr. Charles .M. Intenzo, a nuclear physician at Thomas Jefferson University in Philadelphia found that radiology’s share of procedures involving the administration of radioiodine dropped 7% from 1996 to 2007. At the same time, the number of procedures administered by endocrinologists jumped by nearly one-third (32%).
The total number of such procedures covered by Medicare Part B remained stable over the 10-year period. Medicare covered 13,273 procedures requiring radioiodine in 1996. The total in 2007 was 13,004.
Endocrinology practice revolves around a limited number of applications, so practitioners are naturally attracted to these procedures as a new source of income. Regulatory barriers to their involvement have fallen as the Department of Energy has watered down the minimum training requirements for isotope handling and administration, Intenzo said.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.